SEC Form 4 · accession 0001209191-18-024057
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yoram Palti
Officer — Chief Technology Officer · Director
Period of report
Apr 4, 2018
Accepted (ET)
Apr 5, 2018 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary sharesF1,F2 | Apr 4, 2018 | S | 30,000 | $19.8918 | D | 1,311,054 | I | Bennett Limited |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On April 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $19.60 to $20.375. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F2Professor Palti shares voting and investment power for the shares held by Bennett Limited.